0001704400-19-000001.txt : 20190517 0001704400-19-000001.hdr.sgml : 20190517 20190517110735 ACCESSION NUMBER: 0001704400-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190517 DATE AS OF CHANGE: 20190517 EFFECTIVENESS DATE: 20190517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Anelixis Therapeutics, Inc. CENTRAL INDEX KEY: 0001704400 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-339827 FILM NUMBER: 19834686 BUSINESS ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02130 BUSINESS PHONE: 617-441-7200 MAIL ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02130 D 1 primary_doc.xml X0708 D LIVE 0001704400 Anelixis Therapeutics, Inc. 300 TECHNOLOGY SQUARE, SUITE 400 CAMBRIDGE MA MASSACHUSETTS 02139 617-441-7200 DELAWARE None None Corporation true 2015 Steven Perrin 300 Technology Square Suite 400 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Maeve McNally 300 Technology Square Suite 400 Cambridge MA MASSACHUSETTS 02139 Executive Officer Walter Ogier 300 Technology Square Suite 400 Cambridge MA MASSACHUSETTS 02139 Director Augie Nieto 300 Technology Square Suite 400 Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2019-04-30 false true false 50000 Noble Capital Markets 15768 None None 225 NE Mizner Blvd Suite 150 Boca Raton FL FLORIDA 33432 FL FLORIDA NJ NEW JERSEY false 6000000 1000000 5000000 false 10 100000 0 0 false Anelixis Therapeutics, Inc. Steven Perrin Steven Perrin President 2019-05-15